loadpatents
Patent applications and USPTO patent grants for Nantel; Francois.The latest application filed is for "peptidic and peptidoid bradykinin b1 receptor antagonists and uses thereof".
Patent | Date |
---|---|
Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists Grant 7,932,228 - Nantel , et al. April 26, 2 | 2011-04-26 |
Peptidic And Peptidoid Bradykinin B1 Receptor Antagonists And Uses Thereof App 20080064642 - Guerin; Brigitte ;   et al. | 2008-03-13 |
Method of treating cancer and neuropathic complications induced by chemotherapeutic agents using selective Bradykinin B1 receptor antagonists App 20070015715 - Nantel; Francois ;   et al. | 2007-01-18 |
Eosinophil prostaglandin d2 receptor assays App 20040185509 - Gervais, Francois ;   et al. | 2004-09-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.